Methods for treating fibrotic cancers
US11020451B2 · kind B2 · utility
0Cited by
8References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2014 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Oct 8, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In part, the disclosure relates to methods of treating fibrotic cancers by administering one or more Serum Amyloid Protein (SAP) agonists. In certain aspects, the method further comprises the conjoint administration of an anti-cancer therapeutic, e.g., a chemotherapeutic agent. In certain aspects, the disclosure relates to methods of treating myelofibrosis by administering an SAP agonist and optionally one or more anti-cancer therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.